Company / Financials
Entera Bio Ltd. Financials
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$181.0K
FY2025
Net Income
-$9.5M
FY2025 · -7.3% YoY
Profit Margin
-5271.3%
FY2025 · net income / revenue
ROE
-118.1%
FY2025 · return on equity
Total Assets
$16.0M
FY2025
Total Debt
-
FY2025
Equity
$8.1M
FY2025
ROA
-59.7%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$181.0KNet Income HistoryProfit after all expenses and taxes-$9.5M-7.3% YoYGross Profit HistoryRevenue minus cost of goods sold$9.0KCost of Revenue HistoryDirect costs of producing goods and services sold$172.0KOperating Income HistoryProfit from core business operations before interest and taxes-$9.6M-7.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$340.0K-92.3% YoYR&D Expense HistoryResearch and development spending$4.5M-0.2% YoYIncome Tax HistoryTotal income tax expense$14.0K-51.7% YoYEPS (Basic) HistoryBasic earnings per share$0.25-19.4% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$0.25-19.4% YoY